Health minister Philipp Rösler is determined to reduce costs for Germany's health insurance funds and patients. But last year saw the German pharmaceuticals giants make tidy profits, and they're not prepared to give in without a fight. They argue that developing new, effective medicine is a costly process and fraught with risk.
Be the first to comment